79 - Autoimmune Diabetes Flashcards
Prevalence of type 1 DM
0.5% in Australia
Main antigen in T1DM autoimmunity
Insulin
Role of autoantibodies in T1DM
Probably not causative. Used to diagnose.
T cells probably cause disease.
Stages in development of T1DM
1-5
1) Born with a predisposition, but not with full-blown DM
2) Precipitating event
3) Immune tolerance is broken, appearance of autoantibodies
4) Progressive loss of beta-cell mass
5) Overt diabetes appears, with C-peptide present
Probability of developing diabetes over next fifteen years with appearance of autoantibodies
With three islet autoantibody types, 80% chance of developing DM over fifteen years
Median age of seroconversion to islet autoantibodies
2.1 years
Diagnosis of T1DM
• Clinical – symptoms, weight, ketoacidosis, insulin requirement • Autoantibodies • Latent autoimmune diabetes in adults – GAD antibodies – 10% of type 2
Latent autoimmune diabetes in adults
People who present as type II diabetes in adulthood who actually have type I (have autoantibodies, need insulin)
C-peptide
Peptide that links alpha and beta chains of insulin.
Present in blood with T1DM
Differences in insulin content between T1DM islets
Some have high insulin content, some are completely depleted.
Some have significant inflammatory infiltrate (often islets with less insulin)
Cells present in T1DM islets
Only beta cells missing.
Glucagon can be detected (so alpha cells are intact)
APS-1
Autoimmune polyglandular syndrome 1.
Mutations in AIRE leads to multiple autoimmune disorders (Addison’s, hypoparathyroidism, T1DM susceptibility)
IPEX
Immune dysfunction, polyendocrinopathy, enteropathy, X-linked.
Mutation of FoxP3 gene, which controls Treg cells.
About 80% of children with IPEX develop DM
Can be treated with bone marrow transplantation.
Part of pro-insulin that many T cells recognise in autoimmune DM
C-peptide
Environmental triggers for autoimmunity
1-6
- UV
- Diet
- Drugs
- Tissue specific eg iodine
- “hygiene”
- Infection